Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1790-1795

  Diamant, Zuzana ^b   Timmers, Mieke C ^b   Van Der Veen, Hilly ^b   Page, Clive P ^b   Van Der Meer, Felix J ^b   Sterk, Peter J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HOUSE DUST ALLERGEN;

ADULT; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029934168     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665036     Document Type: Article

References (36)

1. Kay, A. B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87:893-910.
2. Weersink, E. J. M., D. S. Postma, R. Aalbers, and J. G. R. De Monchy. 1994. Early and late asthmatic reaction after allergen challenge. Respir. Med. 88:103-114.
3. Jaques, L. B. 1980. Heparins - anionic polyelectrolyte drugs. Pharmacol. Rev. 31:99-166.
4. Schwartz, L. B., and T. R. Bradford. 1986. Regulation of tryptase from human lung mast cells by heparin. J. Biol. Chem. 261:7372-7379.
5. Lider, O., Y. A. Mekori, T. Miller, R. Bar-Tana, I. Vlodavsky, E. Baharav, I. R. Cohen, and Y. Naparstek. 1990. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur. J. Immunol. 20:493-499.
6. Matzner, Y., G. Marx, R. Drexler, and A. Eldor. 1984. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb. Haemost. 52:134-137.
7. Ekre, H. P. T., B. Fjellner, and O. Hagermark. 1986. Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions. Int. J. Immunopharmacol. 8:277-286.
8. Karnovsky, M. J., and E. R. Edelman. 1994. Heparin/heparan sulphate regulation of vascular smooth muscle behaviour. In J. Black and C. P. Page, editors. Airways and Vascular Remodelling in Asthma and Cardiovascular Disease: Implications for Therapeutic Intervention. Academic Press, London. 45-70.
9. Van der Carr, F. R., and O. B. Williams. 1928. Further studies on the influence of heparin on anaphylactic shock in the guinea pig. J. Immunol. 15:13-20.
10. Bardana, E. J., Jr., M. J. Edwards, and B. Pirofsky. 1969. Heparin as treatment for bronchospasm of asthma. Ann. Allergy 27:108-113.
11. Metzger, W. J., L. B. Atkinson, R. A. Henriksen, and R. H. Fisher. 1992. Low-molecular weight (LMW) heparin blocks late asthmatic response (LAR), bronchial hyperresponsiveness (BHR), and lung eosinophilia in the allergic rabbit (abstract). J. Allergy Clin. Immunol. 89:235.
12. Seeds, E. A. M., J. Hanss, and C. P. Page. 1993. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration. J. Lipid Mediat. 7:269-278.
13. Lucio, J., J. D'Brot, C.-B. Guo, W. M. Abraham, L. M. Lichtenstein, A. Kagey-Sobotka, and A. Ahmed. 1992. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J. Appl. Physiol. 73:1093-1101.
14. Ahmed, T., W. M. Abraham, and J. D'Brot. 1992. Effects of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep. Am. Rev. Respir. Dis. 145:566-570.
15. Ahmed, T., J. D'Brot, W. M. Abraham, J. Lucio, M. J. Robinson, S. Shakir, and B. SanPedro. 1995. Heterogeneity of allergic airway responses: differences in signal transduction? (abstract) Am. J. Respir. Crit. Care Med. 151:A130.
16. Ahmed, T., J. Garrigo, and I. Danta. 1993. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329:90-95.
17. Bowler, S. D., S. M. Smith, and P. S. Lavercombe. 1993. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis. 147:160-163.
18. O'Donnell, W. J., M. A. Rosenberg, K. Kelleher, J. M. Drazen, and E. Israel. 1992. Inhaled heparin does not protect asthmatics against antigen-induced bronchoconstriction (abstract). Am. Rev. Respir. Dis. 145:A422.
19. Ahmed, T., T. Syriste, J. Lucio, W. M. Abraham, M. Robinson, and J. D'Brot. 1993. Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J. Appl. Physiol. 74:1492-1498.
20. Mahadoo, J.A. 1978. Pulmonary administration of heparin. Ph.D. Thesis, University of Saskatchewan, Canada.
21. Quanjer, Ph. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J.-C. Yernault. 1993. Lung volumes and forced ventilatory flows. Eur. Respir. J. 6(Suppl. 16):5-40.
22. Sterk, P. J., L. M. Fabbri, Ph. H. Quanjer, D. W. Cockcroft, P. M. O'Byrne, S. Anderson, E. F. Juniper, and J.-L. Malo. 1993. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur. Respir. J. 6(Suppl. 16):53-83.
23. Durham, S. R. 1991. The significance of late responses in asthma. Clin. Exp. Allergy 21:3-7.
24. Jacques, L. B., J. Mahadoo, and L. W. Kavanagh. 1976. Intrapulmonary heparin: a new procedure for anticoagulant therapy. Lancet ii: 1157-1161.
25. 4 in normal subjects: comparison and interaction with methacholine. Am. Rev. Respir. Dis. 136:979-984.
26. Diamant, Z., M. C. Timmers, H. van der Veen, B. S. Friedman, M. De Smet, M. Depré, D. Hilliard, E. H. Bel, and P. J. Sterk. 1995. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J. Allergy Clin. Immunol. 95: 42-51.
27. Altman, G. A. 1991. Practical Statistics for Medical Research, 1st ed. Chapman and Hall, London.
28. Inman, M.D., R. Watson, D. W. Cockcroft, B. J. O. Wong, F. E. Hargreave, and P. M. O'Byrne. 1995. Reproducibility of allergen-induced early and late asthmatic responses. J. Allergy Clin. Immunol. 95: 1191-1195.
29. Cavigioli, G., B. Mastropasqua, A. Pelucchi, L. Marazzini, and A. Foresi. 1993. Reproducibility of allergen-induced asthma and associated increase in bronchial responsiveness to methacholine in asthmatic children. Ann. Allergy 70:411-417.
30. Wenzel, S. E., A. A. Fowler, and L. B. Schwartz. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am. Rev. Respir. Dis. 137:1002-1008.
31. Ghosh, T. K., P. S. Eis, J. M. Mullaney, C. L. Ebert, and D. L. Gill. 1988. Competitive, reversible, and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin. J. Biol. Chem. 263:11075-11079.
32. Diaz, P., M. C. Gonzalez, F. R. Galleguillos, P. Ancic, O. Cromwell, D. Shepherd, S. R. Durham, G. J. Gleich, and A. B. Kay. 1989. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am. Rev. Respir. Dis. 139: 1383-1389.
33. O'Byrne, P. M. 1988. Allergen-induced airway hyperresponsiveness. J. Allergy Clin. Immunol. 81:119-127.
34. 2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J. Clin. Invest. 90:2292-2298.
35. Coyle, A. J., D. Uchida, S. J. Ackerman, W. Mitzner, and C. G. Irvin. 1994. Role of cationic proteins in the airway. Am. J. Respir. Crit. Care Med. 150:S63-S71.
36. Martineau, P., and L. M. Vaughan. 1995. DIAS rounds: heparin inhalation for asthma. Ann. Pharmacother. 29:71-73.